AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

153.270

-0.920-0.60%

Volume:1.46M

Turnover:240.92M

Market Cap:74.36B

PE:38.01

High:154.100

Open:152.550

Low:150.800

Close:154.190

52wk High:272.649

52wk Low:149.850

Shares:485.15M

Float Shares:483.95M

Volume Ratio:1.05

T/O Rate:0.30%

Dividend:4.12

Dividend Rate:2.69%

EPS(TTM):4.033

EPS(LYR):8.706

ROE:6.66%

ROA:6.58%

PB:2.82

PE(LYR):17.61

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CSL LIMITED

Exchange:

ASX

Establishment Date:

1916

Employees:

29904

Office Location:

655 Elizabeth Street,Melbourne,Victoria,Australia

Website:

http://www.csl.com

Zip Code:

3000

Phone:

Fax:

61 3 9389 1434

Introduction:

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":153.27,"timestamp":1771564320000,"preClose":154.19,"halted":0,"volume":1455538,"delay":0,"changeRate":-0.00596666450483162,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":4.032654017268165,"marketStatus":"Market Closed","change":-0.92,"latestTime":"02-20 16:12:00 AEDT","open":152.55,"high":154.1,"low":150.8,"amount":240922095,"amplitude":0.021402,"askPrice":154,"askSize":280,"bidPrice":153,"bidSize":844,"shortable":3,"etf":0,"ttmEps":4.032654017268165,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":154.19,"dividendRate":0.026971,"openAndCloseTimeList":[[1771542000000,1771563600000]],"volumeRatio":1.046357419869602,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.58%","roe":"6.66%","lyrEps":8.706043,"volumeRatio":1.046357419869602,"shares":485151394,"dividePrice":4.120203,"high":154.1,"amplitude":0.021402,"preClose":154.19,"low":150.8,"week52Low":149.85,"pbRate":"2.82","psRate":"3.42","week52High":272.649,"institutionHeld":0,"latestPrice":153.27,"committee":0.501779,"eps":4.032654017268165,"divideRate":0.026882,"volume":1455538,"delay":0,"ttmEps":4.032654017268165,"open":152.55,"prevYearClose":172.65,"prevWeekClose":150.01,"prevMonthClose":181.42,"prevQuarterClose":172.65,"fiveDayClose":150.01,"twentyDayClose":178.41,"sixtyDayClose":182.95,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013182154300910737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","defaultRemindTime":1773097200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":881503,"yearFounded":1916,"employeeNum":29904,"address":"655 Elizabeth Street,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9389 1911","officeFax":"61 3 9389 1434"},"stockCompanyDetail":{"websiteUrl":"http://www.csl.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":-0.1297},{"period":"3month","weight":-0.143},{"period":"6month","weight":-0.2841},{"period":"1year","weight":-0.3963},{"period":"ytd","weight":-0.1123}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.0666},{"period":"6month","weight":0.055},{"period":"1year","weight":0.2181},{"period":"ytd","weight":0.0215}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.021186},{"month":2,"riseRate":0.516129,"avgChangeRate":0.004842},{"month":3,"riseRate":0.709677,"avgChangeRate":0.017393},{"month":4,"riseRate":0.612903,"avgChangeRate":0.004445},{"month":5,"riseRate":0.548387,"avgChangeRate":0.022962},{"month":6,"riseRate":0.625,"avgChangeRate":0.021489},{"month":7,"riseRate":0.65625,"avgChangeRate":0.03445},{"month":8,"riseRate":0.5,"avgChangeRate":0.001555},{"month":9,"riseRate":0.5,"avgChangeRate":0.005815},{"month":10,"riseRate":0.6875,"avgChangeRate":0.032851},{"month":11,"riseRate":0.65625,"avgChangeRate":0.027695},{"month":12,"riseRate":0.625,"avgChangeRate":0.008863}],"exchange":"ASX","name":"CSL LIMITED","nameEN":"CSL LIMITED"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":null}}